Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F9RE
|
|||
Former ID |
DNC000175
|
|||
Drug Name |
Allylamines
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Squalene monooxygenase (SQLE) | Target Info | Inhibitor | [1] |
KEGG Pathway | Steroid biosynthesis | |||
Sesquiterpenoid and triterpenoid biosynthesis | ||||
Metabolic pathways | ||||
Biosynthesis of secondary metabolites | ||||
Biosynthesis of antibiotics | ||||
Pathwhiz Pathway | Steroid Biosynthesis | |||
Reactome | Cholesterol biosynthesis | |||
Activation of gene expression by SREBF (SREBP) |
References | Top | |||
---|---|---|---|---|
REF 1 | Differential inhibition of fungal amd mammalian squalene epoxidases by the benzylamine SDZ SBA 586 in comparison with the allylamine terbinafine. Arch Biochem Biophys. 1997 Apr 15;340(2):265-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.